메뉴 건너뛰기




Volumn 67, Issue 4, 2018, Pages 1348-1359

Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL EVALUATION; CLINICAL RESEARCH; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FAT CONTENT; FATTY LIVER; FEMALE; FRACTIONATION; GOLD STANDARD; HEALTH INSURANCE; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTON DENSITY FAT FRACTION; RADIATION ATTENUATION; RADIATION EXPOSURE; TRANSIENT ELASTOGRAPHY; AREA UNDER THE CURVE; DIAGNOSTIC IMAGING; ELASTOGRAPHY; LIVER; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

EID: 85042148368     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.29639     Document Type: Article
Times cited : (267)

References (52)
  • 1
    • 84976479130 scopus 로고    scopus 로고
    • Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
    • Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84.
    • (2016) Hepatology , vol.64 , pp. 73-84
    • Younossi, Z.M.1    Koenig, A.B.2    Abdelatif, D.3    Fazel, Y.4    Henry, L.5    Wymer, M.6
  • 3
    • 78650486196 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
    • Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-131.
    • (2011) Gastroenterology , vol.140 , pp. 124-131
    • Williams, C.D.1    Stengel, J.2    Asike, M.I.3    Torres, D.M.4    Shaw, J.5    Contreras, M.6
  • 4
  • 6
    • 84923893879 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
    • Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148:547-555.
    • (2015) Gastroenterology , vol.148 , pp. 547-555
    • Wong, R.J.1    Aguilar, M.2    Cheung, R.3    Perumpail, R.B.4    Harrison, S.A.5    Younossi, Z.M.6
  • 7
    • 79960029926 scopus 로고    scopus 로고
    • Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
    • Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-285.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 274-285
    • Vernon, G.1    Baranova, A.2    Younossi, Z.M.3
  • 8
    • 0141510580 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
    • Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003;98:2042-2047.
    • (2003) Am J Gastroenterol , vol.98 , pp. 2042-2047
    • Harrison, S.A.1    Torgerson, S.2    Hayashi, P.H.3
  • 9
    • 84924938800 scopus 로고    scopus 로고
    • Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies
    • Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 2015;13:643-654.
    • (2015) Clin Gastroenterol Hepatol , vol.13 , pp. 643-654
    • Singh, S.1    Allen, A.M.2    Wang, Z.3    Prokop, L.J.4    Murad, M.H.5    Loomba, R.6
  • 11
    • 84944381776 scopus 로고    scopus 로고
    • Incorporation of noninvasive measures of liver fibrosis into clinical practice: diagnosis and prognosis
    • Asrani SK. Incorporation of noninvasive measures of liver fibrosis into clinical practice: diagnosis and prognosis. Clin Gastroenterol Hepatol 2015;13:2190-2204.
    • (2015) Clin Gastroenterol Hepatol , vol.13 , pp. 2190-2204
    • Asrani, S.K.1
  • 13
    • 84892881288 scopus 로고    scopus 로고
    • Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    • Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014;20:475-485.
    • (2014) World J Gastroenterol , vol.20 , pp. 475-485
    • Sumida, Y.1    Nakajima, A.2    Itoh, Y.3
  • 14
    • 33750617920 scopus 로고    scopus 로고
    • Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
    • Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44:874-880.
    • (2006) Hepatology , vol.44 , pp. 874-880
    • Merriman, R.B.1    Ferrell, L.D.2    Patti, M.G.3    Weston, S.R.4    Pabst, M.S.5    Aouizerat, B.E.6
  • 17
    • 80052012241 scopus 로고    scopus 로고
    • Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis
    • Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54:1082-1090.
    • (2011) Hepatology , vol.54 , pp. 1082-1090
    • Hernaez, R.1    Lazo, M.2    Bonekamp, S.3    Kamel, I.4    Brancati, F.L.5    Guallar, E.6
  • 19
    • 80052996528 scopus 로고    scopus 로고
    • Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
    • Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34:729-749.
    • (2011) J Magn Reson Imaging , vol.34 , pp. 729-749
    • Reeder, S.B.1    Cruite, I.2    Hamilton, G.3    Sirlin, C.B.4
  • 20
    • 84865569519 scopus 로고    scopus 로고
    • Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial
    • Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H, et al. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 2012;56:922-932.
    • (2012) Hepatology , vol.56 , pp. 922-932
    • Le, T.A.1    Chen, J.2    Changchien, C.3    Peterson, M.R.4    Kono, Y.5    Patton, H.6
  • 21
    • 84925339397 scopus 로고    scopus 로고
    • Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
    • Loomba R, Sirlin CB, Ang B, Bettencourt R, Jain R, Salotti J, et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 2015;61:1239-1250.
    • (2015) Hepatology , vol.61 , pp. 1239-1250
    • Loomba, R.1    Sirlin, C.B.2    Ang, B.3    Bettencourt, R.4    Jain, R.5    Salotti, J.6
  • 22
    • 85027925485 scopus 로고    scopus 로고
    • Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD
    • Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012;36:22-29.
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 22-29
    • Permutt, Z.1    Le, T.A.2    Peterson, M.R.3    Seki, E.4    Brenner, D.A.5    Sirlin, C.6
  • 23
    • 84876907610 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis
    • Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422-431.
    • (2013) Radiology , vol.267 , pp. 422-431
    • Tang, A.1    Tan, J.2    Sun, M.3    Hamilton, G.4    Bydder, M.5    Wolfson, T.6
  • 24
    • 84878274416 scopus 로고    scopus 로고
    • Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy
    • Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013;267:767-775.
    • (2013) Radiology , vol.267 , pp. 767-775
    • Idilman, I.S.1    Aniktar, H.2    Idilman, R.3    Kabacam, G.4    Savas, B.5    Elhan, A.6
  • 25
    • 84995360076 scopus 로고    scopus 로고
    • MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice
    • Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice. J Hepatol 2016;65:1006-1016.
    • (2016) J Hepatol , vol.65 , pp. 1006-1016
    • Dulai, P.S.1    Sirlin, C.B.2    Loomba, R.3
  • 26
    • 77958154016 scopus 로고    scopus 로고
    • Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes
    • Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010;36:1825-1835.
    • (2010) Ultrasound Med Biol , vol.36 , pp. 1825-1835
    • Sasso, M.1    Beaugrand, M.2    de Ledinghen, V.3    Douvin, C.4    Marcellin, P.5    Poupon, R.6
  • 27
    • 85010743428 scopus 로고    scopus 로고
    • Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease
    • Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 2017;152:598-607.
    • (2017) Gastroenterology , vol.152 , pp. 598-607
    • Park, C.C.1    Nguyen, P.2    Hernandez, C.3    Bettencourt, R.4    Ramirez, K.5    Fortney, L.6
  • 28
    • 84959449613 scopus 로고    scopus 로고
    • Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography
    • Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016;150:626-637.
    • (2016) Gastroenterology , vol.150 , pp. 626-637
    • Imajo, K.1    Kessoku, T.2    Honda, Y.3    Tomeno, W.4    Ogawa, Y.5    Mawatari, H.6
  • 29
    • 84856708238 scopus 로고    scopus 로고
    • The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroScan
    • Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroScan. Clin Res Hepatol Gastroenterol 2012;36:13-20.
    • (2012) Clin Res Hepatol Gastroenterol , vol.36 , pp. 13-20
    • Sasso, M.1    Miette, V.2    Sandrin, L.3    Beaugrand, M.4
  • 30
    • 84890119533 scopus 로고    scopus 로고
    • Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population
    • Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2014;34:102-109.
    • (2014) Liver Int , vol.34 , pp. 102-109
    • Chon, Y.E.1    Jung, K.S.2    Kim, S.U.3    Park, J.Y.4    Park, Y.N.5    Kim, D.Y.6
  • 31
    • 85010832078 scopus 로고    scopus 로고
    • Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
    • Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Ledinghen V, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 2017;66:1022-1030.
    • (2017) J Hepatol , vol.66 , pp. 1022-1030
    • Karlas, T.1    Petroff, D.2    Sasso, M.3    Fan, J.G.4    Mi, Y.Q.5    de Ledinghen, V.6
  • 32
    • 85020777481 scopus 로고    scopus 로고
    • Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter
    • Wong VW, Petta S, Hiriart JB, Camma C, Wong GL, Marra F, et al. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. J Hepatol 2017;67:577-584.
    • (2017) J Hepatol , vol.67 , pp. 577-584
    • Wong, V.W.1    Petta, S.2    Hiriart, J.B.3    Camma, C.4    Wong, G.L.5    Marra, F.6
  • 33
    • 33644521965 scopus 로고    scopus 로고
    • Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations
    • Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006;18:411-412.
    • (2006) Eur J Gastroenterol Hepatol , vol.18 , pp. 411-412
    • Foucher, J.1    Castera, L.2    Bernard, P.H.3    Adhoute, X.4    Laharie, D.5    Bertet, J.6
  • 34
    • 85020065411 scopus 로고    scopus 로고
    • Controlled attenuation parameter (CAP) with the XL probe of the FibroScan(R): a comparative study with the M probe and liver biopsy
    • de Lédinghen V, Hiriart JB, Vergniol J, Merrouche W, Bedossa P, Paradis V. Controlled attenuation parameter (CAP) with the XL probe of the FibroScan(R): a comparative study with the M probe and liver biopsy. Dig Dis Sci 2017; doi: 10.1007/s10620-017-4638-3.
    • (2017) Dig Dis Sci
    • de Lédinghen, V.1    Hiriart, J.B.2    Vergniol, J.3    Merrouche, W.4    Bedossa, P.5    Paradis, V.6
  • 35
    • 85011602148 scopus 로고    scopus 로고
    • Controlled attenuation parameter using the FibroScan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population
    • Chan WK, Nik Mustapha NR, Wong GL, Wong VW, Mahadeva S. Controlled attenuation parameter using the FibroScan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population. United European Gastroenterol J 2017;5:76-85.
    • (2017) United European Gastroenterol J , vol.5 , pp. 76-85
    • Chan, W.K.1    Nik Mustapha, N.R.2    Wong, G.L.3    Wong, V.W.4    Mahadeva, S.5
  • 36
    • 85038237482 scopus 로고    scopus 로고
    • Performance characteristics of vibration-controlled transient elastography for evaluation of non-alcoholic fatty liver disease
    • Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, et al. Performance characteristics of vibration-controlled transient elastography for evaluation of non-alcoholic fatty liver disease. Hepatology 2017; doi: 10.1002/hep.29489.
    • (2017) Hepatology
    • Vuppalanchi, R.1    Siddiqui, M.S.2    Van Natta, M.L.3    Hallinan, E.4    Brandman, D.5    Kowdley, K.6
  • 37
    • 84949959656 scopus 로고    scopus 로고
    • Heritability of hepatic fibrosis and steatosis based on a prospective twin study
    • Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 2015;149:1784-1793.
    • (2015) Gastroenterology , vol.149 , pp. 1784-1793
    • Loomba, R.1    Schork, N.2    Chen, C.H.3    Bettencourt, R.4    Bhatt, A.5    Ang, B.6
  • 38
    • 84929266699 scopus 로고    scopus 로고
    • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
    • Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 2015;385:956-965.
    • (2015) Lancet , vol.385 , pp. 956-965
    • Neuschwander-Tetri, B.A.1    Loomba, R.2    Sanyal, A.J.3    Lavine, J.E.4    Van Natta, M.L.5    Abdelmalek, M.F.6
  • 39
    • 84983183920 scopus 로고    scopus 로고
    • Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
    • Doycheva I, Cui J, Nguyen P, Costa EA, Hooker J, Hofflich H, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther 2016;43:83-95.
    • (2016) Aliment Pharmacol Ther , vol.43 , pp. 83-95
    • Doycheva, I.1    Cui, J.2    Nguyen, P.3    Costa, E.A.4    Hooker, J.5    Hofflich, H.6
  • 40
    • 84874115167 scopus 로고    scopus 로고
    • Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease
    • Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;37:630-639.
    • (2013) Aliment Pharmacol Ther , vol.37 , pp. 630-639
    • Patel, N.S.1    Peterson, M.R.2    Brenner, D.A.3    Heba, E.4    Sirlin, C.5    Loomba, R.6
  • 41
    • 84931321456 scopus 로고    scopus 로고
    • Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study
    • Zarrinpar A, Gupta S, Maurya MR, Subramaniam S, Loomba R. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study. Gut 2016;65:1546-1554.
    • (2016) Gut , vol.65 , pp. 1546-1554
    • Zarrinpar, A.1    Gupta, S.2    Maurya, M.R.3    Subramaniam, S.4    Loomba, R.5
  • 42
    • 84992456193 scopus 로고    scopus 로고
    • Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study
    • Cui J, Chen CH, Lo MT, Schork N, Bettencourt R, Gonzalez MP, et al. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology 2016;64:1547-1558.
    • (2016) Hepatology , vol.64 , pp. 1547-1558
    • Cui, J.1    Chen, C.H.2    Lo, M.T.3    Schork, N.4    Bettencourt, R.5    Gonzalez, M.P.6
  • 44
    • 84870819164 scopus 로고    scopus 로고
    • Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease
    • Wong VW, Vergniol J, Wong GL, Foucher J, Chan AW, Chermak F, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012;107:1862-1871.
    • (2012) Am J Gastroenterol , vol.107 , pp. 1862-1871
    • Wong, V.W.1    Vergniol, J.2    Wong, G.L.3    Foucher, J.4    Chan, A.W.5    Chermak, F.6
  • 45
    • 41249100719 scopus 로고    scopus 로고
    • Non-invasive evaluation of liver fibrosis using transient elastography
    • Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835-847.
    • (2008) J Hepatol , vol.48 , pp. 835-847
    • Castera, L.1    Forns, X.2    Alberti, A.3
  • 46
    • 84921785945 scopus 로고    scopus 로고
    • Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease
    • Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416-425.
    • (2015) Radiology , vol.274 , pp. 416-425
    • Tang, A.1    Desai, A.2    Hamilton, G.3    Wolfson, T.4    Gamst, A.5    Lam, J.6
  • 47
    • 85021735463 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
    • Caussy C, Soni M, Cui J, Bettencourt R, Schork N, Chen CH, et al. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. J Clin Invest 2017;127:2697-2704.
    • (2017) J Clin Invest , vol.127 , pp. 2697-2704
    • Caussy, C.1    Soni, M.2    Cui, J.3    Bettencourt, R.4    Schork, N.5    Chen, C.H.6
  • 48
    • 84888298670 scopus 로고    scopus 로고
    • Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
    • Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013;58:1930-1940.
    • (2013) Hepatology , vol.58 , pp. 1930-1940
    • Noureddin, M.1    Lam, J.2    Peterson, M.R.3    Middleton, M.4    Hamilton, G.5    Le, T.A.6
  • 49
    • 84888290605 scopus 로고    scopus 로고
    • Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis
    • Reeder SB. Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis. Hepatology 2013;58:1877-1880.
    • (2013) Hepatology , vol.58 , pp. 1877-1880
    • Reeder, S.B.1
  • 50
    • 16244366026 scopus 로고
    • Index for rating diagnostic tests
    • Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-35.
    • (1950) Cancer , vol.3 , pp. 32-35
    • Youden, W.J.1
  • 51
    • 0020083498 scopus 로고
    • The meaning and use of the area under a receiver operating characteristic (ROC) curve
    • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
    • (1982) Radiology , vol.143 , pp. 29-36
    • Hanley, J.A.1    McNeil, B.J.2
  • 52
    • 84867834721 scopus 로고    scopus 로고
    • Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration
    • Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 2012;36:1011-1014.
    • (2012) J Magn Reson Imaging , vol.36 , pp. 1011-1014
    • Reeder, S.B.1    Hu, H.H.2    Sirlin, C.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.